Study detects neutralizing antibodies against SARS-CoV-2 in stool samples of infants breastfed by vaccinated mothers with the potential to provide passive immunity against the…
A new mRNA HIV vaccine technology encodes key proteins to form virus-like particles (VLPs) that induce neutralizing antibodies safely and effectively in animal studies with minimal side effects. Researchers from…
Researchers identify a molecular interaction between the COVID-19 vaccine adenovirus vector and platelet factors which may be the cause of rare blood clots linked to the vaccine. An international team of…
New encapsulating technology for whole-cell vaccines stimulates enhanced immunogenicity against Escherichia coli in a mouse model, shaping the future of urinary tract infection (UTI) vaccines. Recurrent…
The largest real-world observational study of the third ‘booster’ dose of the mRNA COVID-19 vaccine demonstrates its effectiveness against severe SARS-CoV-2-related illness, hospitalization, and…
A plain language summary of how well the single-dose Janssen vaccine works and how safe it is. The Janssen (Beerse,…
A historic moment: WHO recommends deployment of a malaria vaccine finally developed after a 100-year endeavour. The WHO have advised that the RTS,S/AS01 vaccine, also known as Mosquirix, developed by GlaxoSmithKline (London, England) over the last 30 years in…
Phase III trials for the VLA1553 vaccine against chikungunya virus indicated promising results by inducing protective CHIKV neutralizing antibody titers…
Complete the form below to get your free COVID-19 pathogenesis, prevention and treatment eBook. Receive three free articles from our…
Novel and emerging infectious diseases can be a serious threat to human health and the global economy. To mitigate these…
